Latest EQL Pharma News & Updates

See the latest news and media coverage for EQL Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

EQL Pharma

Swedish generic and specialty pharmaceutical developer and marketer

eqlpharma.com

Headquarters: Sweden
Company type: Public company
Number of employees: 10–60
Industry: Pharmaceuticals

Last updated Today

Latest news about EQL Pharma

In short: EQL Pharma reported record sales of 120.2 MSEK for Q4 2025/26, though margins declined due to logistics issues and one-off costs.

Company announcements

July 27 EQL Pharma

EQL Pharma recruits Oskar Karmlid as new CSCO

He takes office in October 2026 and replaces Martin Kristofferson who has been interim manager.

July 24 EQL Pharma

EQL Pharma publishes annual report for 2025/2026

The annual report is available on the website and contains financial information for the fiscal year.

July 17 EQL Pharma

EQL Pharma calls for annual general meeting 2026

The meeting will be held on 20 August in Lund with proposals for a new board member and incentive program.

July 15 EQL Pharma

EQL Pharma's Mellozzan approved in Kazakhstan

The approval was obtained via partner Abdi Ibrahim and covers the strength 3 mg. 5 mg is expected in December 2026.

Media coverage

July 27 ZoneBourse

DNB Carnegie lowers the fundamental value of EQL Pharma

DNB Carnegie has revised downward its EBIT (operating profit) forecasts for the generics specialist EQL Pharma by 3 to 8%, and...

July 10 Dagens industri

EQL Pharma under investigation for insider trading

An employee at the pharmaceutical company EQL Pharma is suspected of insider trading, confirms the company's CEO Axel Schörling to Di. A former employee is also suspected.

May 9 The Globe and Mail

EQL Pharma Delivers Record Sales but Margin Hit Forces Sharper Focus and Slower Pipeline

EQL Pharma reported record quarterly sales of SEK 120.2 million for the fourth quarter, up 6% year-on-year, but profitability weakened as gross margin fell to...

May 8 FinanzNachrichten.de

EQL Pharma AB: Year-end Report April 2025 - March 2026

During the quarter, sales rose to SEK 120.2 million, an increase of 6% from SEK 113.3 million in the previous year. Growth for next year...

Never miss news about EQL Pharma

Track EQL Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

EQL Pharma competitors & trending companies

Browse news for competitors to EQL Pharma and other trending companies.